Table A3.
ARB recommendation
| Losartan (Cozaar) | Candesartan (Atacand) | Valsartan (Diovan) | Irbesartan (Avapro) | Olmesartan (Benicar) | Telmisartan (Micardis) | Azilsartan (Edarbi) | Eprosartan (Teveten) | |
|---|---|---|---|---|---|---|---|---|
| Initial dose | 50 mg daily | 16 mg daily | 80 mg daily | 150 mg daily | 20 mg daily | 40 mg daily | 80 mg daily | 600 mg daily |
| Titration |
50 mg daily ↓ Irbesartan 150 mg daily ↓ Irbesartan 300 mg daily |
16 mg daily ↓ 32 mg daily |
80 mg daily ↓ 160 mg daily ↓ 240 mg daily ↓ 320 mg daily |
150 mg daily ↓ 300 mg daily |
20 mg daily ↓ 40 mg daily |
40 mg daily ↓ 80 mg daily |
80 mg daily |
600 mg daily ↓ 800 mg daily |
| Target dose | Irbesartan 300 mg daily | 12– 32 mg daily | 160–320 mg daily | 300 mg daily | 40 mg daily | 40‐80 mg daily | 80 mg daily | 600‐ 800 mg daily |
| Max dose | Irbesartan 300 mg daily | 32 mg daily | 320 mg daily | 300 mg daily | 40 mg daily | 80 mg daily | 80 mg daily | 800 mg daily |
| Monitoring | BP, heart rate, BUN, SCr, K per above protocol | |||||||
| Contraindications | Allergy, angioedema, moderate to severe aortic stenosis, bilateral renal artery stenosis, pregnancy, coadministration with aliskiren in patients with diabetes | |||||||
Note: Bold text represents preferred medications